Carl Kraus

Chief Medical Officer

Carl is the Chief Medical Officer of Aceragen. He is an Infectious Disease physician with more than 20 years’ experience in drug development, ranging from discovery and first-in-man studies through late-phase/risk-management program implementation.

He has been the Principal Investigator for multiple NIAID, NCI and DoD funded research programs and is also a former FDA Medical Officer, serving in the Office of Antimicrobial Products. Carl has held scientific and management roles with UnitedHealth Group, PRA Health Sciences, and Nanotherapeutics (now Resilience, Inc.).